Meet us at DCAT Week, the premier business development event for companies engaged in pharmaceutical development and manufacturing. Contact us today to schedule a meeting! Noramco is a global leader in controlled substance APIs for the pharmaceutical industry, focusing on ...
Two Organizations Will Build on Strengths to Address Differentiated End-Use Markets Wilmington, DE 19 September 2019 – Noramco announced today that its industry-leading cannabinoids business will become a separate company – Purisys, LLC. Purisys will focus exclusively on acting as ...
Support for emerging market includes positions on rigorous science, consumer safety and monitoring of intermediates and end-products Wilmington, DE – Noramco, a leading manufacturer of cannabidiol (CBD) and related compounds presented testimony and answered questions at the Food and Drug ...
New activity will add options and potential for cost savings to Noramco’s robust CBD platform in support of emerging markets Wilmington, DE – Noramco, a leading manufacturer of cannabinoids, and Willow Biosciences Inc. (“Willow”), a leading developer of biosynthetic production ...
DCAT Week 2020
March 23 – 26, 2019
New York City
November 5 – 7, 2019
November 3 – 6, 2019
San Antonio, TX
September 10 – 12, 2019